C
Cryosa
Medical device company developing novel treatments for obstructive sleep apnea
About Cryosa
Cryosa, Inc. is a clinical-stage company focused on developing innovative treatments for moderate to severe Obstructive Sleep Apnea (OSA). The company operates in the medical technology sector and targets patients suffering from OSA, a condition characterized by repeated interruptions in breathing during sleep. Cryosa's proprietary technology offers a minimally invasive, incisionless solution that leverages a controlled cooling process to reduce tissue and open airways, eliminating the need for masks, hoses, or implants. The business model revolves around clinical trials, regulatory approvals, and eventual commercialization of their treatment. Revenue generation is anticipated through the sale of their medical devices and associated therapies once they receive market approval. Cryosa has successfully raised $8.25 million in Series A-2 funding to further develop their breakthrough treatment. The company is currently enrolling participants in a U.S. pilot study, ARCTIC 3, to evaluate the safety and effectiveness of their therapy.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Cryosa is 1.8K monthly website visits, up 0% over the last three months. Cryosa's team declined 18.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Cryosa in the Arden Hills ecosystem
The Cryosa office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sante Ventures
HOYA CORPORATION
Solas BioVentures
Other known investors2 additional known investors
Brightstone Venture Capital
Gravity Fund
Source: Dealroom Talent Intelligence.
See Cryosa’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







